AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25909982 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular assist device (Impella 2.5)
Number of subjects: 427
Study 25909982 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk scores (Euroscore, STS mortality score, STS morbidity and mortality score, Mayo Clinic risk score, New York state PCI risk score)
Number of subjects: 427
Study 25909982 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk scores
Number of subjects: 427
Study 22496093 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating music
Number of subjects: 60
Study 22496093 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedating music
Number of subjects: 60
Study 22496093 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 60
Study 22041945 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (n = 156)
Number of subjects: 313
Study 22041945 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 157)
Number of subjects: 313
Study 18775942 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) in addition to standard care
Number of subjects: 104
Study 18775942 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 104
Study 16514326 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold detection threshold
Number of subjects: 191
Study 16514326 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration perception threshold and loss of ankle reflexes
Number of subjects: 191
Study 16514326 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold detection threshold (when vibration perception threshold and loss of ankle reflexes were removed)
Number of subjects: 191
Study 16514326 — intervention group
Group type: COMPARATOR
Intervention: Heat pain tests
Number of subjects: 191
Study 15269869 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniplate osteosynthesis and intermaxillary ligation
Number of subjects: 59
Study 15269869 — intervention group
Group type: COMPARATOR
Intervention: Arch bar splints fixation and intermaxillary ligation
Number of subjects: 59
Study 11712724 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 13
Study 9149190 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral preparation (one bottle of magnesium citrate and two 'Dulcolax' tablets)
Number of subjects: 70
Study 9149190 — intervention group
Group type: COMPARATOR
Intervention: Enema preparation (two Fleet's enemas)
Number of subjects: 70
Study 8196323 — intervention group
Group type: EXPERIMENTAL
Intervention: aiconol in the form of oil (Group 1, 51 subjects)
Number of subjects: 164
Study 8196323 — intervention group
Group type: EXPERIMENTAL
Intervention: protein dietetic caviar with 3% aiconol (Group 2, 35 subjects)
Number of subjects: 164
Study 8196323 — intervention group
Group type: EXPERIMENTAL
Intervention: protein-oil emulsion containing 20% aiconol (Group 3, 38 subjects)
Number of subjects: 164
Study 8196323 — intervention group
Group type: EXPERIMENTAL
Intervention: gelatin aiconol in capsules (Group 4, 40 subjects)
Number of subjects: 164
Study 3286579 — intervention group
Group type: EXPERIMENTAL
Intervention: Early refeeding (6-h)
Number of subjects: 90
Study 3286579 — intervention group
Group type: COMPARATOR
Intervention: Late refeeding (24-h)
Number of subjects: 90
Study 3286579 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk or cow's milk diet in both early and late refeeding groups
Number of subjects: 90
Study 31616933 — intervention group
Group type: EXPERIMENTAL
Intervention: Agriculture and nutrition behavior change communication (BCC) intervention implemented through community-based childcare centers
Number of subjects: 1248
Study 31616933 — intervention group
Group type: EXPERIMENTAL
Intervention: Agriculture and nutrition behavior change communication (BCC) intervention
Number of subjects: 1248
Study 30243109 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered empowerment intervention
Number of subjects: 0
Study 30243109 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 29182212 — intervention group
Group type: EXPERIMENTAL
Intervention: Total etch approach using phosphoric acid
Number of subjects: 64
Study 29182212 — intervention group
Group type: COMPARATOR
Intervention: Self-etch approach using a Universal dentine bonding agent (Scotchbond Universal)
Number of subjects: 64
Study 26016658 — intervention group
Group type: COMPARATOR
Intervention: Nap (30 minutes)
Number of subjects: 25
Study 26016658 — intervention group
Group type: COMPARATOR
Intervention: Bright light exposure (30 minutes under bright blue light)
Number of subjects: 25
Study 26016658 — intervention group
Group type: COMPARATOR
Intervention: Wake (30 minutes watching a documentary)
Number of subjects: 25
Study 26016658 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 minutes watching a documentary under dim orange light)
Number of subjects: 25
Study 23188121 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 2303
Study 23188121 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 2303
Study 23188121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2303
Study 21645332 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg perhexiline maleate
Number of subjects: 50
Study 21645332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19546692 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.05 mg/kg
Number of subjects: 100
Study 19546692 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.2 mg/kg
Number of subjects: 100
Study 19546692 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin 0.4 mg/kg
Number of subjects: 100
Study 19546692 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam 0.5 mg/kg
Number of subjects: 100
Study 16988202 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25 mg administered as a 15-minute 50-mL intravenous infusion
Number of subjects: 0
Study 16988202 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron 0.25 mg administered as a 30-second 5-mL infusion
Number of subjects: 0
Study 15561476 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 10th percentile
Number of subjects: 102
Study 15561476 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 30th percentile
Number of subjects: 102
Study 15561476 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 50th percentile
Number of subjects: 102
Study 15561476 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for breath COs at or below the 70th percentile
Number of subjects: 102
Study 11095085 — intervention group
Group type: EXPERIMENTAL
Intervention: ILC + stent
Number of subjects: 35
Study 11095085 — intervention group
Group type: COMPARATOR
Intervention: ILC only
Number of subjects: 35
Study 9243334 — intervention group
Group type: EXPERIMENTAL
Intervention: External valvuloplasty with Silicone prosthesis under Doppler control
Number of subjects: 113
Study 9243334 — intervention group
Group type: COMPARATOR
Intervention: High ligation or disconnection of the junction
Number of subjects: 113
Study 9243334 — intervention group
Group type: EXPERIMENTAL
Intervention: Both operations (External valvuloplasty and High ligation/disconnection)
Number of subjects: 113
Study 8500313 — intervention group
Group type: EXPERIMENTAL
Intervention: Media (TV, radio, newspapers)
Number of subjects: 0
Study 8500313 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood promotion
Number of subjects: 0
Study 8500313 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct mail
Number of subjects: 0
Study 8500313 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite promotion
Number of subjects: 0
Study 8500313 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral by other study participants
Number of subjects: 0
Study 3108980 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation (Ve) plots
Number of subjects: 6
Study 3108980 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 production (VCO2) plots
Number of subjects: 6
Study 3108980 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory exchange ratio (R) plots
Number of subjects: 6
Study 3108980 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory equivalent for oxygen (Ve/VO2) plots
Number of subjects: 6
Study 30121611 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support system
Number of subjects: 180
Study 30121611 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support system plus automated daily supportive/reminder text messages
Number of subjects: 180
Study 30121611 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated daily supportive/reminder text messages alone
Number of subjects: 180
Study 30121611 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual follow-up care
Number of subjects: 180
Study 27042788 — intervention group
Group type: EXPERIMENTAL
Intervention: DynaMesh®‐IPOM
Number of subjects: 76
Study 27042788 — intervention group
Group type: COMPARATOR
Intervention: Gore® DUALMESH® Plus
Number of subjects: 76
Study 24211172 — intervention group
Group type: EXPERIMENTAL
Intervention: Device monitoring with the ForeseeHome device
Number of subjects: 1520
Study 24211172 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1520
Study 23314695 — intervention group
Group type: EXPERIMENTAL
Intervention: IgM-enriched immunoglobulin (5 ml/kg via 8 h IV-infusion for three consecutive days)
Number of subjects: 33
Study 23314695 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 ml/kg via 8 h IV-infusion for three consecutive days)
Number of subjects: 33
Study 20063934 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention + SMS plan reminder
Number of subjects: 149
Study 20063934 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention + SMS goal reminder
Number of subjects: 149
Study 20063934 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 149
Study 19082406 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of 0.5% hyperbaric bupivacaine with 2.5 microg of sufentanil and 30 microg of clonidine (CLON/HYPER Group)
Number of subjects: 22
Study 19082406 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of 0.5% isobaric bupivacaine with 2.5 microg of sufentanil and 30 microg of clonidine (CLON/ISO Group)
Number of subjects: 22
Study 20554428 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic reminders (ERs)
Number of subjects: 148
Study 20554428 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electronic reminders)
Number of subjects: 148
Study 16210048 — intervention group
Group type: EXPERIMENTAL
Intervention: IVL745 (20 mg, twice daily for 7 days)
Number of subjects: 16
Study 16210048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 16210048 — intervention group
Group type: EXPERIMENTAL
Intervention: IVL745
Number of subjects: 16
Study 12898875 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive obese patients
Number of subjects: 31
Study 12898875 — intervention group
Group type: COMPARATOR
Intervention: Patients with systemic hypertension and normal BMI (control group)
Number of subjects: 31
Study 9797161 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetization transfer ratios in multiple sclerosis lesions
Number of subjects: 19
Study 9797161 — intervention group
Group type: EXPERIMENTAL
Intervention: Myelin water percentages in multiple sclerosis lesions
Number of subjects: 19
Study 9797161 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetization transfer ratios and myelin water percentages
Number of subjects: 19
Study 9098463 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/desogestrel
Number of subjects: 100
Study 9098463 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/gestodene
Number of subjects: 100
Study 9098463 — intervention group
Group type: COMPARATOR
Intervention: Control group (IUD)
Number of subjects: 100
Study 2473515 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid cardioplegic solution (35 g dextran 40 added to St Thomas II solution)
Number of subjects: 55
Study 2473515 — intervention group
Group type: COMPARATOR
Intervention: Standard crystalloid cardioplegic solution
Number of subjects: 55
Study 348734 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.035% w/v alexidine.2HCL mouthwash
Number of subjects: 214
Study 348734 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 214
Study 11304817 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtenon ropivacaine
Number of subjects: 21
Study 11304817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30656460 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered sequential protocol (group 1)
Number of subjects: 63
Study 30656460 — intervention group
Group type: COMPARATOR
Intervention: High-pitch spiral protocol (group 2)
Number of subjects: 63
Study 29738810 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel tobacco vapor product (NTV)
Number of subjects: 60
Study 29738810 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarettes (CC)
Number of subjects: 60
Study 29738810 — intervention group
Group type: COMPARATOR
Intervention: Smoking abstinence (SA)
Number of subjects: 60
Study 27188795 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS)
Number of subjects: 340
Study 27188795 — intervention group
Group type: COMPARATOR
Intervention: Placebo transcranial direct current stimulation (tDCS)
Number of subjects: 340
Study 25008877 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO treatment (200 IU/(kg.d) by intravenous infusion for 7 days)
Number of subjects: 40
Study 25008877 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 40
Study 25008877 — intervention group
Group type: COMPARATOR
Intervention: Normal control group (healthy full-term neonates)
Number of subjects: 40
Study 21859516 — intervention group
Group type: COMPARATOR
Intervention: Nutritional intervention consisting of joint meal preparation and activities for children and parents, administered once weekly by a nutrition expert for 6 months.
Number of subjects: 348
Study 20525960 — intervention group
Group type: EXPERIMENTAL
Intervention: Toluidine blue screening (TBS) group
Number of subjects: 7975
Study 20525960 — intervention group
Group type: COMPARATOR
Intervention: Visual screening group (control)
Number of subjects: 7975
Study 17603411 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Intervention (EI)
Number of subjects: 40
Study 17603411 — intervention group
Group type: COMPARATOR
Intervention: Community Mental Health Team (CMHT)
Number of subjects: 40
Study 15842140 — intervention group
Group type: EXPERIMENTAL
Intervention: Shennong No. 33 (SN33) in addition to comprehensive therapy
Number of subjects: 129
Study 15842140 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive therapy without SN33
Number of subjects: 129
Study 15842140 — intervention group
Group type: EXPERIMENTAL
Intervention: Shennong No. 33 (SN33)
Number of subjects: 129
Study 12855972 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Group (prophylactic macular photocoagulation)
Number of subjects: 156
Study 12855972 — intervention group
Group type: COMPARATOR
Intervention: No Treatment Group (control)
Number of subjects: 156
Study 10569644 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (LA) 600 mg/d
Number of subjects: 31
Study 10569644 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (AT) 400 IU/d
Number of subjects: 31
Study 10569644 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of LA and AT
Number of subjects: 31
Study 8906516 — intervention group
Group type: EXPERIMENTAL
Intervention: DD genotype
Number of subjects: 515
Study 8906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined IMT plaque values
Number of subjects: 515
Study 8906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Total population
Number of subjects: 515
Study 8906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype
Number of subjects: 515
Study 8906516 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid plaques
Number of subjects: 515
Study 1878735 — intervention group
Group type: EXPERIMENTAL
Intervention: Human recombinant GM-CSF
Number of subjects: 20
Study 1878735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7063290 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide aerosol (0.5 mg twice a day)
Number of subjects: 46
Study 7063290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 29381789 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Self‐Administered 24‐h recalls (ASA24s)
Number of subjects: 1075
Study 29381789 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐d food records (4DFRs)
Number of subjects: 1075
Study 29381789 — intervention group
Group type: EXPERIMENTAL
Intervention: Food‐frequency questionnaires (FFQs)
Number of subjects: 1075
Study 29381789 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple ASA24s and 4DFR
Number of subjects: 1075
Study 29381789 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy adjustment for FFQs
Number of subjects: 1075
Study 27187845 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude journaling intervention
Number of subjects: 70
Study 27187845 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 70
Study 24707021 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovaza (3360 mg docosahexaenoic acid + eicosapentaenoic acid per day)
Number of subjects: 25
Study 24707021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 24707021 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Lovaza and Placebo
Number of subjects: 25
Study 22379242 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic event detection (AED) using a positive airway pressure (PAP) device
Number of subjects: 115
Study 22379242 — intervention group
Group type: COMPARATOR
Intervention: Manual scoring of polysomnography (PSG)
Number of subjects: 115
Study 22379242 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP AED
Number of subjects: 115
Study 22379242 — intervention group
Group type: COMPARATOR
Intervention: Manual scoring
Number of subjects: 115
Study 20709301 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AQE)
Number of subjects: 75
Study 20709301 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-based Exercise (LBE)
Number of subjects: 75
Study 20709301 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 75
Study 17431065 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS to the right DLPFC
Number of subjects: 45
Study 17431065 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS to the left DLPFC
Number of subjects: 45
Study 17431065 — intervention group
Group type: COMPARATOR
Intervention: 1 Hz rTMS to the left DLPFC
Number of subjects: 45
Study 17431065 — intervention group
Group type: COMPARATOR
Intervention: sham TMS
Number of subjects: 45
Study 16025975 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 0
Study 16025975 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study 12197195 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg
Number of subjects: 42
Study 12197195 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 42
Study 10220696 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid pretreatment (methylprednisolone, 30 mg/kg)
Number of subjects: 20
Study 10220696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7880703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 micrograms
Number of subjects: 24
Study 7880703 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 50 mg
Number of subjects: 24
Study 7880703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl in 0.25% bupivacaine (25 mg)
Number of subjects: 24
Study 7880703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl in 0.125% bupivacaine (12.5 mg)
Number of subjects: 24
Study 1369865 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization of the forearm
Number of subjects: 97
Study 1369865 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-arm plaster
Number of subjects: 97
Study 1369865 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-arm plaster with X-ray follow-up (7th to 10th day after reduction)
Number of subjects: 97
Study 1369865 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 97
Study 638249 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose 'concentration x time' (C x T) schedule of 1 mg every 12 hr for 3 days
Number of subjects: 19
Study 638249 — intervention group
Group type: COMPARATOR
Intervention: Single injections of 12 mg/sq m/dose
Number of subjects: 19
Study 29476238 — intervention group
Group type: EXPERIMENTAL
Intervention: Low calorie, high polyphenol cranberry extract beverage (CEB)
Number of subjects: 78
Study 29476238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 28040386 — intervention group
Group type: EXPERIMENTAL
Intervention: New two-thumb technique (nTTT)
Number of subjects: 0
Study 28040386 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard two finger technique (TFT)
Number of subjects: 0
Study 28040386 — intervention group
Group type: COMPARATOR
Intervention: Standard two thumb technique (TTHT)
Number of subjects: 0
Study 25711320 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard consent form
Number of subjects: 4473
Study 25711320 — intervention group
Group type: COMPARATOR
Intervention: Concise consent form
Number of subjects: 4473
Study 24390522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 0
Study 24390522 — intervention group
Group type: COMPARATOR
Intervention: Calorie-restricted diet
Number of subjects: 0
Study 22465047 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.006 mg/kg/day of GH subcutaneously (group A, n=60)
Number of subjects: 120
Study 22465047 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B, n=60)
Number of subjects: 120
Study 19204509 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC-201 (up to ten 30 g Hb units)
Number of subjects: 688